Quantitative determination of the representative triterpenoids in the extracts of Ganoderma lucidum with different growth stages using high-performance liquid chromatography for evaluation of their 5α-reductase inhibitory properties

Food Chemistry

Volumn 133, Issue 3, 2012, Pages 1034-1038

  Liu, Jie ^a,d   Kurashiki, Kenji ^a   Fukuta, Atsuko ^a   Kaneko, Shuhei ^b   Suimi, Yoshitaro ^c   Shimizu, Kuniyoshi ^a   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Forestry and Forest Products Research Institute   (Japan)

^c Bisoken and Co Ltd   (Japan)

^d NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

5 Reductase inhibition; Ganoderma lucidum; Growth stage; HPLC analysis; Triterpenoids

Indexed keywords

ANALYTICAL RESULTS; ANALYTICAL SYSTEMS; ELUTION PROFILES; GANODERIC ACID; GANODERMA; GANODERMA LUCIDUM; GROWTH STAGE; GROWTH STAGES; HPLC ANALYSIS; INHIBITORY ACTIVITY; LINEAR GRADIENTS; MOBILE PHASE; QUANTITATIVE DETERMINATIONS; REDUCTASE INHIBITORS; TRITERPENOIDS;

CHROMATOGRAPHY;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ALCOHOL; GANODERIC ACID A; GANODERIC ACID D; GANODERIC ACID DM; GANODERIC ACID TR; GANODERMA LUCIDUM EXTRACT; GANODERMATRIOL; STEROID 5ALPHA REDUCTASE INHIBITOR; TRITERPENOID; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; ENZYME INHIBITION; FEMALE; GANODERMA LUCIDUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; QUANTITATIVE ANALYSIS; RAT;

GANODERMA; GANODERMA LUCIDUM;

EID: 84862804812     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2012.01.034     Document Type: Article

References (22)

1. M. Berovic, J. Habijanic, I. Zore, I. Wraber, D. Hodzar, and B. Boh Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides Journal of Biotechnology 103 2003 77 86
2. R.Y. Chen, and D.Q. Yu Development of triterpenes from Ganoderma lucidum Acta Pharmaceutica Sinica 25 1990 940 953
3. J.J. Gao, N. Nakamura, B.S. Min, A. Kirakawa, F. Zuo, and M. Hattori Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products Chemical & Pharmaceutical Bulletin 52 2004 688 695
4. Y.H. Gao, and S.F. Zhou Chemopreventive and tumoricidal properties of Ling Zhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae). II. Mechanism considerations International Journal of Medical Mushrooms 6 2004 219 230
5. M. Hirotani, C. Ino, and T. Furuya Comparative study on the strain-specific triterpenoid components of Ganoderma lucidum Phytochemistry 33 1993 379 382
6. M. Kubo, H. Matsuda, M. Nogami, S. Arichi, and T. Takahashi Ganoderma lucidum IV. Effects on disseminated intra vascular coagulation Yakugaku Zasshi 103 1983 871 877
7. K. Kumakura, H. Kumakura, M. Ogura, and F. Eguchi Pharmacological effects of Ganoderma lucidum collected from ume (Japanese apricot) trees Journal of Wood Science 54 6 2008 502 508
8. S.Y. Lee, and H.M. Rhee Cardiovascular effects of mycelium extract of Ganoderma lucidum: Inhibition of sympathetic outflow as a mechanism of its hypotensive action Chemical and Pharmaceutical Bulletin 38 1990 1359 1364
9. Z.B. Lin, and H.N. Zhang Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms Acta Pharmacologica Sinica 25 2004 1387 1395
10. J. Liu, R. Fujita, M. Sato, K. Shimizu, F. Konishi, and K. Noda The effect of strain, growth stage and cultivating condition of Ganoderma lucidum on 5α-reductase inhibition Journal of Wood Science 51 2 2005 189 192
11. J. Liu, K. Kurashiki, K. Shimizi, and R. Kondo 5α-Reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum Biological and Pharmceutical Bulletin 29 2 2006 392 395
12. J. Liu, K. Shimizu, F. Konishi, S. Kumamoto, and R. Kondo The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum Bioorganic and Medicinal Chemistry 15 14 2007 4966 4972
13. J. Liu, J. Shiono, K. Shimizu, A. Kukita, T. Kukita, and R. Kondo Ganoderic acid DM: Anti-androgenic osteoclastogenesis inhibitor Bioorganic and Medicinal Chemistry Letters 19 8 2009 2154 2157
14. J. Luo, and Z.B. Lin Advances of pharmacological effects of triterpenes from Ganoderma lucidum Acta Pharmaceutica Sinica 37 2002 574 578
15. B.B. Matijasic, and I. Rogelj Lactobacillus K7 - A new candidate for a probiotic strain Food Technology and Biotechnology 38 2000 113 119
16. T. Mizuno, G. Wang, J. Zhang, H. Kawagishi, T. Nishitoba, and J. Li Studies of bioactive substances and medical effects of the Ganoderma lucidum: Substances and medicinal effects Food Review International 11 1995 151 166
17. R.D. Petrova, S.P. Wasser, J.A. Mahajna, C.M. Denchev, and E. Nevo Potential role of medicinal mushrooms in breast cancer treatment: current knowledge and future perspectives International Journal of Medical Mushrooms 7 2005 141 146
18. A. Pokorny, and A. Musar Abstracts of the 10th international conference on global impacts of applied microbiology biotechnology 1995 University of Copenhagen Copenhagen 141
19. D. Sliva Ganoderma lucidum in cancer research Leukemia Research 30 2006 767 768
20. J.T. Xie, C.Z. Wang, S. Wicks, J.J. Yin, J. Kong, and J. Li Gnoderma lucidum extract inhibits proliferation of SW480 human colorectal cancer cells Experimental Oncology 28 2006 25 29
21. M. Yang, X.M. Wang, S.H. Guan, and J.M. Xia Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry Journal of the American Society for Mass Spectrometry 18 2007 927 939
22. J.W.M. Yuen, and M.D.I. Gohel Anticancer effects of Ganoderma lucidum: A review of scientific evidence Nutrition and Cancer 53 2005 11 17